WSC
TTRX

Wellington Shields & Co’s Turn Therapeutics TTRX Stock Holding History

Wellington Shields & Co’s Portfolio TTRX Stock Details TTRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$480K Hold
65,732
– – 0.11% 161
2026
Q1 		$210K Hold
65,732
– – 0.05% 236
2025
Q4 		$259K Buy
+65,732
New +$274K 0.06% 213

Other funds holding TTRX

SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
DI
DDFG Inc Thousand Oaks, California $504M AUM 18.61% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BA
Bridgewater Advisors New York $1.83B AUM 22.9% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return
TS
Tamar Securities Woodland Hills, California $1.07B AUM 26.86% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wellington Shields & Co's TTRX Position: Q2 2026 in Review

Wellington Shields & Co held its Turn Therapeutics (TTRX) position steady in Q2 2026 at 65,732 shares worth $480K. The position accounts for 0.11% of the portfolio, ranked #161.

Wellington Shields & Co first reported a position in TTRX in Q4 2025 and has held it in 3 quarters since. 29 funds tracked by Wall St. Rank hold TTRX as of Q2 2026.

  • Wellington Shields & Co held 65,732 shares of Turn Therapeutics worth $480K as of Q2 2026.
  • Wellington Shields & Co left its Turn Therapeutics share count unchanged in Q2 2026.
  • Turn Therapeutics made up 0.11% of Wellington Shields & Co's portfolio in Q2 2026, its #161 holding.
  • Wellington Shields & Co first reported a position in Turn Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 29 funds tracked by Wall St. Rank held Turn Therapeutics as of Q2 2026.

Based on Wellington Shields & Co's 13F filing for Q2 2026, filed 10 Aug 2026.